CVS
$91.13-1.51%
as of close, Oct 27, 2026
☾ AH $91.13 -1.51%
CVS — CVS Health Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED
50.060.070.080.090.0100.00100.0M$91.13—20162019202120242026
2026-10-27
Price$91.13
MA20$96.36
MA50$85.37
Vol20.7M
Key stats#
Price data
- Price
- $91.13
- YTD price return
- +14.83%
- YTD total return
- +18.36%
- Next earnings
- Nov 4, 2026 · Before open
- Market cap
- 116.6B
- Enterprise value
- 180.9B
- Shares outstanding
- 1.3B
- 52W low
- $69.51
- 52W high
- $110.68
- From 52W high
- -17.66%
- From 52W low
- +31.10%
- 52W range
- 53%
- Beta
- 0.60
Volume
- Rel volume
- 0.51×
- 30D volume
- 9M
- 30D $ vol
- 798.8M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- −$323.7M
Form 4 transactions by trade date, as filed; latest on file 2026-05-21.
Fundamentals
- Sales (ttm)
- 415.1B
- Sales/share
- $324.55
- EPS (ttm)
- $3.82
- FCF (ttm)
- 11.8B
- FCF/share
- $9.19
- Book value/share
- $62.32
- Net margin
- 1.18%
- ROE
- 6.14%
- ROA
- 1.93%
- Debt / equity
- 0.75×
- Current ratio
- 0.87
Growth (CAGR, ttm) · 10Y
- Sales
- +7.36%+6.96%+8.32%+9.55%
- Net income
- +7.93%+18.14%-7.45%+0.16%
- FCF
- +146.13%-12.70%+0.24%+5.21%
- Shares
- +0.84%-0.14%-0.62%+1.84%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +6.54%+18.85%-6.89%-1.29%
- Sales/share
- +6.47%+7.11%+9.00%+7.58%
- FCF/share
- +144.09%-12.58%+0.87%+3.31%
- Book value/share
- +2.15%+3.25%+2.34%+6.69%
- Dividend/share
- +0.00%+4.81%+5.87%+5.55%
- Price
- +10.54%+11.19%+0.68%+0.40%
- Total return
- +13.93%+15.46%+4.11%+3.57%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 23.9×
- P/OI (ttm)
- 14.1×
- Fwd P/E
- 11.0×
- P/S (ttm)
- 0.3×
- P/B (mrq)
- 1.5×
- P/FCF (ttm)
- 9.9×
- EV/EBITDA (fy)
- 14.1×
- EV/Sales (ttm)
- 0.4×
- FCF yield (ttm)
- 10.09%
- Dividend yield (fwd)
- 2.92%
- Dividend yield (ttm)
- 2.92%
- Dividend/share (fwd)
- $2.66
- Buyback yield (realized, 1y)
- -0.84%
- Shareholder yield (realized, 1y)
- 3.06%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 2.93%
Vs own 10Y history
- P/E
- 79th
- P/OI
- 80th
- P/S
- 30th
- P/B
- 53rd
- P/FCF
- 60th
Bar = where today’s multiple sits in CVS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-1.51%
5D
-3.82%
1M
+2.24%
3M
-14.89%
YTD
+14.83%
1Y
+10.53%
5Y
+3.45%
Recent filings#
- Aug 178-K · CVS Health Announces Board Changes
- Aug 5Earnings · Earnings release — EPS $2.58 vs $1.87 est. (+38.0%); revenue $106.10B (+7% y/y) 5.1%
Financial statements
Open full CVS financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
